Mapreg

MAPREG’s seasoned team is dedicated to delivring 21^stcentury life-changing treatments for the CNS

**Isabelle Villey, PhD MBA**
CEO & COO
(15 years seniority, 12 at MAPREG)

gary brandam — **Gary Brandam**
Market adoption
(10 years seniority)

**Sylvie Gabriel, MD MBA**
Market Access, pricing
former VP at Sanofi, Ipsen, Galderma
(30 years seniority)

Key Board Members & Advisors

**Olivier Schlüter, PhD**
Managing Director Novaliq
Founder & CFO Dermaliq,
Former banker (30 years seniority)

**Dr Marion Roy, MD**
former VP at Sanofi
Corporate licensing
(30 years seniority)

**Arnaud Limal, MBA**
Partner, Drake Start investment bank
(35 years seniority)

Cedrik — **Cédrik de Ternay**
CIO, GENERALI FR
(main shareholder)

Marie-Noelle — **Marie-Noëlle Castel, PharmD, MBA**
former global head Sanofi
Nervous system disorders & alliances
(30 years seniority)

Clinical Advisors : Prof. Philippe Fossati (FR), Dr. Florence Buten-Ducuing (FR), Prof. Pierre Demaricourt (FR), Prof. Pierre Blier( CA), Dr. Barbara Mason (US), Prof. Maurizio Fava (US)

Translational Drug Dev Support from Dr. Denis Ravem (former head of drug dev. at Servier, 30 years seniority in drug dev) acting drug dev.